Background: This review aims to assist cancer clinical researchers in choosing between the two most widely used measures of cancer-specific health-related quality of life: the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and Functional Assessment of Cancer Therapy-General (FACT-G).
introduction
Choosing an outcome measure of health-related quality of life (HRQoL) for clinical research with cancer patients should be undertaken with consideration to specific objectives, samples, treatments and resources [1] [2] [3] [4] . A variety of measures are available, but two cancer-specific questionnaires are especially widely used: the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) [5] and the Functional Assessment of Cancer Therapy-General (FACT-G) [6] . Both are 'core' questionnaires that can be supplemented by a range of tumour-, treatment-or symptom-specific 'modules' as required. Combined use of a core measure and module is advantageous because the module offers enhanced sensitivity to disease and treatment effects while the core measure enables results to be compared across the full gamut of cancer clinical contexts.
The current article compares the QLQ-C30 and FACT-G with regard to content, scale structure, psychometric properties, interpretability, availability of modules and accessibility of questionnaires and supporting information and offers guidance on how to use this information to choose between them for any given study. The article has been written to aid cancer clinical researchers who lack detailed understanding of psychometrics or time to digest the extensive literature on the measurement properties of these two questionnaires.
materials and methods
Information about content, format, scale structure, response options, recall period, time to administer, modes of administration, translations, access and available modules was extracted from the QLQ-C30 and FACT-G users' manuals [5, 6] and websites (http://groups.eortc.be/qol/ and http:// www.facit.org/). A systematic review of the literature was undertaken to identify all English-language articles reporting evidence for the psychometric properties of the QLQ-C30 and FACT-G. Relevant articles were identified via reference to manuals and websites and through searches of Medline and PsycINFO. Databases were searched in May 2009 using the name of each questionnaire as a keyword combined with the medical subject heading (MeSH) term 'psychometrics' and the key word 'psychometric$ OR valid$ OR reliab$'. Results were limited to articles published since 1993, the year in which original validation articles for both questionnaires were published [7, 8] . Further papers were identified manually via the reference lists of returned articles.
We focused exclusively on reports that mentioned reliability, validity, responsiveness or information useful in interpreting scores of the QLQ-C30 or FACT-G among the aims in their abstracts. Definitions of relevant properties and the criteria used to evaluate these are given in Table 1 . To be included, an article had to report data on one or more of these properties for either the QLQ-C30 or FACT-G, or both. Evidence for each property was independently rated by two reviewers until interrater reliability of kappa > 0.60 was achieved on at least 25 pairs of ratings. Disagreements were resolved through discussion. Each reviewer rated a similar proportion of articles concerned with the QLQ-C30 versus FACT-G.
Because evaluation of psychometric properties is influenced by methodological and sample variables, special attention was paid to reports that compared the QLQ-C30 and FACT-G within the same study. We were also interested in studies that asked patients or health professionals about their preferences for one instrument over the other. Results from studies comparing the QLQ-C30 and FACT-G were summarised across reports with a view to identifying a trend in favour of one or other instrument. Correlations reported across studies were weighted by sample size and averaged following a procedure designed to obtain average weighted effect sizes (ESs) [11] .
results

characteristics of the two questionnaires
A comparison of QLQ-C30 and FACT-G characteristics is presented in Table 2 . A comparison of the EORTC and Functional Assessment of Chronic Illness Therapy (FACIT) suites more generally is presented in Table 3 .
ratings of evidence for psychometric properties
Database searches returned 382 articles reporting on the QLQ-C30 and 122 on the FACT-G. Of these, and articles identified in manuals, on websites and in reference lists, 80 articles were found that reported psychometric data amenable to appraisal using our checklist: 46 articles reported data on the QLQ-C30, 32 on the FACT-G, and 2 on both. Interrater reliability of kappa >0.60 was achieved for ratings of internal consistency (kappa = 0.71), internal structure (kappa = 0.80), convergent validity (kappa = 0.67) and information to assist interpretation of scores (kappa = 0.63). Other properties were reported too infrequently for interrater reliability to be properly assessed. In these cases, both reviewers continued to rate each report and consensus was reached via discussion. A summary of ratings is presented in Table 4 . Details of evidence in specific languages and tumour and/or treatment contexts are available on request.
With regard to 'reliability', evidence for internal consistency and test-retest reliability is more substantial for the FACT-G. However, when comparing ratings for internal consistency, it should be noted that these typically summarise Cronbach's alphas across nine multi-item scales for the QLQ-C30 compared with just five scales for the FACT-G and that corresponding scales of the QLQ-C30 contain fewer items. Of the QLQ-C30's scales, the two-item cognitive functioning scale has most often demonstrated low internal consistency (alpha < 0.70)-in one case, alpha 0.19 [13] . Interrater reliability between self-and proxy-reports has been evaluated only for the QLQ-C30, with findings from five studies yielding mixed results depending on the domains involved [14] .
Evidence for the 'validity' of the QLQ-C30 and FACT-G is available from a similarly diverse range of populations and clinical settings. However, evidence for content validity is available for the QLQ-C30 only from its original validation with European lung cancer patients [7] , while the FACT-G has undergone content validation in USA patients with mixed cancer diagnoses [8] and further, partial validation in Chinese patients (cancer types not specified) [15] and Korean stage I-III breast cancer patients [16] . While evidence for internal structure has been more favourable for the QLQ-C30, this may be due partly to the different analyses used for the QLQ-C30 versus FACT-G: Multitrait scaling has been used most widely for the QLQ-C30 and factor and item response theory analyses for the FACT-G. Numerous studies have provided strong support for convergent and discriminant validity of both the QLQ-C30 and FACT-G. Convergent validity for both instruments has usually been tested with reference to other HRQoL measures and/or measures of anxiety, depression or mood. Discriminant validity has usually been tested by comparing scores from patients grouped by performance status, disease stage or treatment status. Ratings of limited were most often given for these properties due to authors' lack of hypotheses rather than failure to converge or discriminate where hypotheses had been made. At least some of the QLQ-C30 scales have also been found to predict survival in patients with mesothelioma [17] , prostate [18] and lung [19] cancers.
Evidence for 'responsiveness' is similar across the QLQ-C30 and FACT-G. Floor and ceiling effects have only been analysed for the QLQ-C30, with substantial effects of both kinds (particularly ceiling effects) found in most cases.
While both questionnaires are available in a large number of language translations, evidence for the psychometric properties of the QLQ-C30 exists for a greater range than for the FACT-G, which has been evaluated principally in American English and Spanish. This probably reflects the origins of the FACT-G in the United States and the QLQ-C30 in Europe.
interpretability of scores
Fourteen articles focussed solely on interpreting data from the QLQ-C30 or FACT-G [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Of these, two [32, 33] were reviews that summarised results from a further eight articles for the FACT-G and its modules. A summary of these articles is presented in Table 5 . 
articles comparing the QLQ-C30 and FACT-G
Fourteen articles compared the QLQ-C30 and FACT-G within the same study [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] . Since comparisons of this kind offer the most useful information about relative performance, findings from each are discussed in some detail below. (Table 6) .
Two articles used Rasch analyses to compare scale structure and distribution of scores on the QLQ-C30 and FACT-G [37, 43] . Chang and Cella [43] found that the QLQ-C30 had superior item efficiency [defined as person separation (an index of the ability of items to discriminate participants) divided by the square root of the number of items] while the FACT-G showed better precision (lower standard error of the mean) in measuring the HRQoL of participants with cancer and/or HIV (N = 1163) in the middle of the HRQoL range. Holzner et al. [37] compared the linearity of physical functioning (PF)/ physical well-being (PWB), emotional functioning (EF)/ emotional well-being (EWB) and role functioning (RF)/ functional wellbeing (FWB) in patients with mixed cancer diagnoses (N = 737) and found FACT-G's FWB extended to more extreme levels than QLQ-C30's RF at both ends, leading to greater ceiling effects (defined as a considerable proportion of observations at the maximum possible score) and (to a lesser extent) floor effects (a considerable proportion of observations at the minimum possible score) on the QLQ-C30. Holzner et al. attributed this finding to the fewer items in RF (two items) versus FWB (seven items).
indirect comparisons. Two articles compared scores on the QLQ-C30 and FACT-G in relation to a third measure-performance status [34, 42] . It should be noted that performance status is a clinician-rated construct different from patient-reported HRQoL. As such, performance status does not provide a gold standard but rather a context in which to interpret HRQoL scores. Sharp et al. [34] compared each questionnaire's sensitivity and specificity to high versus low Karnofsky performance status (KPS) in men with metastatic prostate cancer (N = 110). They used the areas under the receiver operating characteristic curve (AUC) as a measure of how accurately each instrument categorised patients' KPS. The value for AUC ranges from 0 to 1 and can be interpreted as follows. A value of 1 represents perfect classification, 100% sensitivity (no false negatives) and 100% specificity (no false positives). A completely random guess would give a point along a diagonal line, with AUC of 0.5. The values for the QLQ-C30 and the FACT-G, respectively, were physical (PF = 0.71; PWB = 0.80), emotional (EF = 0.64; EWB = 0.58), social (SF = 0.79; SWB = 0.59), functional/role (RF = 0.81; FWB = 0.82) and overall quality of life (QoL) (QLQ-C30 global health status/ QoL = 0.74; FACT-G total score = 0.72). Corresponding scales of the two instruments thus performed similarly with the exception of the social, where the QLQ-C30 had a better ratio of true positives to false positives when identifying level of KPS.
Cheung et al. [42] compared the ability of the QLQ-C30 global score and the FACT-G total score to discriminate between patients with mixed cancer diagnoses (N = 437) grouped according to Eastern Cooperative Oncology Group (ECOG) performance status of zero to one versus two to four at + Descriptive statistics of the distribution of scores were presented and <5% of respondents achieved the highest or lowest possible score. 6 Descriptive statistics of the distribution of scores were presented and between 6% and 15% of respondents achieved the highest or lowest possible score. 2 Descriptive statistics of the distribution of scores were presented and more than 15% of respondents achieved the highest or lowest possible score. Responsiveness to change: The ability to detect change over repeated measurements in accordance with hypotheses made regarding clinically important events (e.g., changes in performance, disease or treatment status).
+ Hypotheses were formulated and results were in agreement, using an adequate metric (effect size, standardised response mean, comparison with external standard). 6 Method doubtful (e.g. no hypotheses made and expected direction of change in HRQoL not obvious). 2 Measure found inadequately responsive when a significant change was hypothesised.
Ratings: +, evidence strongly supportive; 6, evidence limited or mixed; 2, evidence unfavourable. For all types of reliability and validity, a rating of + required results to be consistently favourable and produced using sound methodology with a sample of ‡50 participants.
a Adapted from checklists developed as part of the COnsensus-based Standards for the selection of health status Measurement Instruments (COSMIN) [9] and Dementia Outcomes Measurement Suite (DOMS) project [10] . FACT-G, Functional Assessment of Cancer Therapy-General; HRQoL, health-related quality of life; ICC, intraclass correlation coefficient; QLQ-C30, Quality of Life Questionnaire Core 30.
baseline and to detect changes in performance status at 4-week follow-up. They used two indices commonly used in sample size calculation, ES and coefficient of variation (CV) to compare the sample sizes that would be needed by each measure to identify a similar effect. The ES is the ratio of the mean difference to its standard deviation, and the CV is the ratio of the standard deviation to the mean. Both ratios are unit-less because the numerator and denominator are in the same measurement units. ES allows HRQoL effects measured on different scales to be directly compared in terms of the variability among individuals, or 'standard deviation units'. The authors concluded from these findings that the QLQ-C30 global QoL scale would need a sample size 57% larger than that of the FACT-G total score to detect a difference between lower versus higher ECOG performance status with a power of 80%. However, this interpretation did not take into account the fact that CV comprises both true variability and error variation, so should be treated with caution. Cheung et al. found that the test-retest reliability of the two measures was similar for patients who did not change performance status (r = 0.73 FACT-G, r = 0.64 QLQ-C30, P > 0.05).
content comparisons
Five studies asked patients to state their preferences about EORTC versus FACIT measures; one also asked health professionals [35, [44] [45] [46] [47] (Table 7) . There was no clear pattern in terms of preference, complicated by variation in the pools of questionnaires referred to and inconsistency in statistical comparison. However, the French version of the FACT-G was reported to be inadequately worded and intrusive by about a quarter of patients, considerably more than for the QLQ-C30 [45] . Results from patients and health professionals were discordant, with patients favouring the QLQ-C30 but health professionals the FACT-G [47] . An important potential consequence of these issues is failure to complete all questions. Missing item rates, where reported, were low but tended to be slightly higher for the FACT-G. A further article [48] compared the content of the QLQ-C30 and FACT-G and their respective modules for head and neck cancer against the International Classification of Functioning, Disability and Health [49] . The QLQ-C30 was found to offer more comprehensive coverage of concepts relating to 'body functions' and 'activities and participation'. Each was found to offer similarly scant coverage of contextual This article set out to compare the EORTC QLQ-C30 and FACT-G cancer-specific HRQoL questionnaires with a view to informing choice between them. Psychometric data are not decisive in recommending one measure or the other. Differences in the social domains, scale structure and tone of these two instruments are more useful in determining choice on a study-by-study basis.
differences in measurement of social HRQoL
A first important difference concerns the way in which 'social HRQoL' is conceptualised and measured in the QLQ-C30
versus FACT-G. Low correlations between the QLQ-C30's social functioning (SF) and FACT-G's social well-being (SWB) reflect differences in their content; items in SF assess impacts on social activities and family life while those in SWB focus on social support and relationships [44] . This distinction is consistent with SF's better sensitivity and specificity to performance status [34] .
differences in scale structure
Further important differences between the QLQ-C30 and the FACT-G concern their approaches to 'scale structure' and the means of calculating their 'overall scores'. In addition to the physical, emotional, social and functional/role scales offered by both measures, the QLQ-C30 provides brief scales for cognitive functioning, financial impact and a range of symptoms either not assessed by the FACT-G or else subsumed within its well- Numbers indicate the quantity of articles rated as reporting each level of evidence for each property. Numbers in parentheses are percentage of the total number of articles reporting on that property for the measure in question. Psychometric properties: IC, internal consistency; TR, test-retest reliability; IR, interrater reliability; CV, content validity; IS, internal structure; Con V, convergent or divergent validity; DV, discriminant validity; PV, predictive validity; FCE, floor and ceiling effects; Res, responsiveness. NA, not applicable, as information to assist interpretation cannot be unfavourable. being scales. While the QLQ-C30's approach enables scores to be generated for outcomes that may be of specific interest, it provides 15 scores compared with the FACT-G's five, which complicates analysis and incurs problems of multiple hypothesis testing unless decisions are made regarding specific primary and secondary outcomes. An overall score on the QLQ-C30 is generated by averaging responses to just two questions (global health and quality of life), while the FACT-G allows summation of all 27 items.
Classical test theory predicts that scales comprised of a greater number of items should be more reliable and therefore more sensitive and responsive. Cheung et al. [42] provided the most comprehensive test of this hypothesis, but found mixed support for it, with evidence for superior sensitivity and therefore power for cross-sectional comparisons but equivalent test-retest reliability and responsiveness. The potential for lengthier scales to have greater sensitivity and responsiveness has further implications for other corresponding scales, which are longer in the FACT-G in all cases. This may be especially true for the QLQ-C30's PF scale, which is a Guttman scale whereon respondents who report little difficulty for the first items are unlikely to report serious difficulties on subsequent items. As such, only one or two of the five items are likely to be informative for any given respondent.
On the other hand, the multiplicity of issues and symptoms subsumed within each FACT-G scale raises the potential for sensitivity and responsiveness to be reduced because of differential effects among items. Issues and symptoms within each scale are implicitly weighted according to the proportion of items allocated to each. For example, the FACT-G's PWB scale contains items assessing lack of energy, nausea, trouble meeting the needs of one's family, pain, bother caused by side-effects, feeling ill and being forced to spend time in bed. As a result, while the QLQ-C30 scales can be taken more or less at face value, detailed perusal of the FACT-G's item-by-item content is needed within the context of specific objectives and anticipated effects. This is especially true where the objective is to compare the effects of two or more competing interventions; care is needed to ensure that neither is disadvantaged by the items in the FACT-G scales.
Other potential differences between the QLQ-C30 and FACT-G relate to the 'distribution of scores' for various samples and the extent to which each scale is at risk of floor or ceiling effects. The only clear evidence comes from a Rasch analysis by Holzner et al. [37] , which found the FACT-G's FWB to measure both higher and lower levels of HRQoL than the QLQ-C30's RF. More generally, means and standard deviations across scales on both instruments suggest that ceiling rather than floor effects may be of concern in general cancer samples.
differences in concept and tone
A final difference between the QLQ-C30 and FACT-G concerns their respective 'look and feel'. With the exception of its emotional scale, the QLQ-C30 confines its questions to relatively 'objective' aspects of functioning, whereas the FACT-G encourages respondents to reflect on their thoughts and feelings throughout. Studies asking patients and health professionals about relative face validity, ease of comprehension and overall preference have been inconclusive, although the trend has generally favoured the QLQ-C30 [35, [44] [45] [46] [47] . Two FACT-G items seem especially problematic both in terms of respondents' willingness to complete them and their relevance across cancer patients. The first of these relates to worry about dying and the second satisfaction with sex life. While both are important issues in some cancer settings, they may be considered inappropriate in others. The item on sex life is optional and consistently leads to substantial missing data from the social scale, which can still be scored providing responses to 50% or more of the items are available. Normative/ reference data [20] Comparison of norms for Germany, Norway, Denmark and Sweden [21] Using reference data for interpretation [22] Official EORTC reference values for various cancer sites MCIDs [23] Worked example of using norms to develop MCIDs [24] Secondary analysis using clinically relevant anchors [25] Interpreting scores by comparison with ratings of change Dealing with attrition [26] Interpreting data in advanced gastrointestinal cancer FACT-G Normative/ reference data [27] USA norms and heterogeneous cancer reference values [28] USA norms for the FACT-GP [29] Austrian norms and cancer survivor reference values [30] Australian (QLD) norms for the FACT-GP MCIDs [31] Reviews results published until 2002 on anchor and distribution based evidence for the FACT-G, its subscales and various modules [32] Reviews results published until 2004 on anchor and distribution based evidence for the FACT-G, its subscales and various modules [33] Meta-analysis of anchor based evidence for the FACT-G and its subscales 
limitations
The most important limitation of this review concerns possible bias in selecting and comparing evidence for the psychometric properties of the QLQ-C30 versus FACT-G. We included only articles published in English. Also, while research reports of many kinds have potential to provide insights into psychometric properties, we decided that confidence in findings could be increased by focussing on studies that cited evaluation of psychometric properties among the aims in their abstracts. While this approach doubtless led us to underrepresent evidence for the performance of both the QLQ-C30 and FACT-G, it is unlikely to have biased results towards one instrument or the other. For studies that were included, our checklist was intended to maximise objectivity and minimise bias in appraising available evidence. While this article has focused on the QLQ-C30 and FACT-G, it should be remembered that these are just two of a large number of alternative HRQoL measures. Certain objectives may be better served by generic questionnaires that enable comparison of results between health conditions and the general population or alternative cancer-, tumour-, treatment-or symptom-specific questionnaires that offer better coverage of pertinent HRQoL concerns.
conclusions and recommendations for choice of instrument
There is substantial evidence for the reliability and validity of both the EORTC QLQ-C30 and FACT-G in a range of cancer settings, and both are available in a large number of language translations. While psychometric evidence is indecisive, there are important differences between the scale structure, social domains and tone of these two instruments that can be used to inform choice for each particular study. Where research objectives are concerned with the impact of a specific tumour type, treatment or symptom, choice should be guided by (i) the availability and (ii) the established psychometric properties, content and scale structure of specific modules in the EORTC versus FACIT suites. Choice of instrument for studies with participants speaking languages other than English should be guided by the evidence in support of the psychometric versus 8 min) . FACT-G items were more often described as confusing (1.5% versus 0.36%) or upsetting (0.6% versus 0.3%). Data were missing for 5.23% of FACT-G items versus 1.76% QLQ-C30. [45] French patients with carcinoma of unknown primary (N = 68)
Equal proportions (19%) preferred QLQ-C30 and FACT-G; 54% had no preference. 29% regarded FACT-G as inadequately worded versus 19% QLQ-C30 (NS); 24% regarded FACT-G as intrusive versus 3% QLQ-C30 (P < 0.001). Percentage of unanswered items higher for FACT-G (9% versus 5%, P < 0.001). [35] UK patients with oesophageal cancer who had undergone surgery and, in some cases neoadjuvant chemotherapy (N = 57) 33% preferred QLQ-C30 + oesophageal module; 21% FACT-G + oesophageal module; 16% had no preference and remainder did not answer this question (no analyses reported). Data were missing for 1.8% of FACIT items versus 0.5% QLQ (P < 0.01). [46] New Zealand patients with HNC (N = 70-73)
18% said FACT-G + HNC module helped most to describe health problems versus 13% QLQ-C30 + HNC module; 17% preferred one of two other HNC-specific HRQoL questionnaire and the remainder had no preference. No significant differences were found for ease of understanding, length or annoying/ intrusive. [47] USA lung, breast and prostate cancer patients (N = 61) and health professionals (N = 19) 25% patients said QLQ-C30 covered the most issues important to them versus 12% FACT-G. 24% patients said QLQ-C30 covered the most issues with which they would like help versus 7% FACT-G. 21% health professionals said QLQ-C30 covered the most issues important to their patients versus 26% FACT-G. 32% health professionals said the QLQ-C30 covered the most issues which they felt most able to help with versus 37% FACT-G. Remaining patients and health professionals stated preferences for one of two needs assessment measures.
FACT-G, Functional Assessment of Cancer Therapy-General; HNC, head and neck cancer; QLQ-C30, Quality of Life Questionnaire Core 30; NS, not statistically significant. review properties of relevant translated versions. Individual items of the FACT-G should be reviewed to ensure that symptoms and issues included within each scale will not lead to bias within the context of a given study's specific research objectives. These issues being equal, researchers are invited to use the decision tree presented in Figure 1 . This figure provides a simple algorithm to aid cancer clinical researchers in deciding which of the two questionnaires is the most appropriate for their purposes, driven by the outcomes that are of most interest. 
